Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenobarbital vs Phenytoin/Midazolam for Pediatric CSE
NCT03650270Phase 3Completed
- Sponsor
- University of Cape Town
- Start
- Mar 2015
- Primary completion
- Mar 2018
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of phenobarbital in status epilepticus (SE) (2 arms), sponsored by University of Cape Town. Primary endpoint: Differences in anticonvulsant efficacy between different second-line anticonvulsant treatment protocols at 24 hours. Started Mar 2015; status: completed.
02
Drugs
phenobarbital
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on NCT03650270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03650270.